Home07X • FRA
add
Annovis Bio Inc
Previous close
€2.74
Day range
€2.63 - €2.64
Year range
€1.05 - €14.84
Market cap
62.55M USD
Avg Volume
733.00
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.28M | -19.55% |
Net income | -5.54M | -418.96% |
Net profit margin | — | — |
Earnings per share | -0.32 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.24M | 608.84% |
Total assets | 26.74M | 242.20% |
Total liabilities | 2.68M | -75.97% |
Total equity | 24.05M | — |
Shares outstanding | 19.49M | — |
Price to book | 2.22 | — |
Return on assets | -77.25% | — |
Return on capital | -94.16% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.54M | -418.96% |
Cash from operations | -8.10M | -15.16% |
Cash from investing | — | — |
Cash from financing | 19.78M | 348.10% |
Net change in cash | 11.68M | 546.35% |
Free cash flow | -5.93M | -42.97% |
About
Founded
2008
Headquarters
Website
Employees
8
